Molecules 2013, 18
8925
1-(2-Diisopropylaminoethyl)-4-phenyl-1H-1,2,3-triazole (10d). Using the general procedure 232 mg
(85%) of the title compound were prepared from azide 9b (170 mg) and phenylacetylene (112 μL).
1H-NMR (CDCl3): δ 7.84–7.81 (m, 3H, HAr), 7.45 (t, J = 6.4 Hz, 2H, HAr), 7.35 (t, J = 6.4 Hz, 1H, HAr),
4.38 (t, J = 6.5 Hz, 2H, CH2), 3.04 (septet, J = 6.5 Hz, 2H, CH(CH3)2), 2.95 (t, J = 6.5 Hz, 2H, CH2),
13
0.99 (d, J = 6.5 Hz, 12H, CH3); C-NMR (CDCl3): δ 147.1 (NCH=C), 130.9 (C, CAr), 128.8 (CH,
CHAr), 127.9 (CH, CHAr), 125.7 (CH, CHAr), 120.8 (CH, NCH=), 51.2 (CH2, CH2N), 48.7 (CH, CHN),
45.7 (CH2, CH2N), 20.8 (CH3). HRMS calculated for C16H25N4: 273.2079; found 273.2086 [(M+H)+].
Ethyl 1-(2-(1,3-dioxolan-2-yl)ethyl)-1H-1,2,3-triazole-4-carboxylate (10e). Using the general
procedure 203 mg (84%) of the title compound were prepared from azide 9c (143 mg), ethyl propiolate
(102 μL), and 8 (6 mg, 1 mol%). Spectroscopic data for 10e were consistent with previously reported
1
data for this compound [20]. H-NMR (CDCl3): δ 8.12 (s, 1H, NCH=C), 4.93 (t, J = 4.0 Hz, 1H,
OCHO), 4.58 (t, J = 7.0 Hz, 2H, CH2CH2N), 4.43 (q, J = 7.0 Hz, OCH2CH3), 4.03–3.93 (m, 2H,
OCH2CH2O), 3.93–3.83 (m, 2H, OCH2CH2O), 2.33 (dt, J = 4.0; 7.0 Hz, CHCH2CH2), 1.41 (t,
J = 7.0 Hz, 3H, OCH2CH3). 13C-NMR (CDCl3): δ 160.2 (C, C=O), 139.3 (C, =C–CO2Et), 127.5 (CH,
CH=C), 127.5 (CH, O–CH–O), 64.55 (CH2, O–CH2–CH2–O), 64.48 (CH2, O–CH2–CH2–O), 60.6
(CH2, OCH2–CH3), 45.0 (CH2, CH2–CH2–N), 33.2 (CH2, CH2–CH2–N), 13.7 (CH3).
N,N-Dimethyl-1-(1-phenethyl-1H-1,2,3-triazol-4-yl)methanamine (10f). Using the general procedure
202 mg (88%) of the title compound were prepared from (2-azidoethyl)benzene (9d, 147 mg),
dimethylprop-2-ynylamine (111 μL) and 8 (6 mg, 1 mol%). Spectroscopic data for 10f were consistent
1
with previously reported data for this compound [20]. H-NMR (CDCl3): δ 7.31–7.21 (m, 4H,
HAr + NCH=C), 7.09 (d, J = 7.0 Hz, 2H, HAr), 4.58 (t, J = 7.0 Hz, 2H, PhCH2CH2), 3.57 (s, 2H,
13
CH2NMe2), 3.21 (t, J = 7.0 Hz, 2H, PhCH2CH2), 2.23 (s, 6H, NMe2). C-NMR (CDCl3): δ 144.7 (C,
NCH=C), 137.0 (C, CAr), 128.7 (CH, CHAr), 128.6 (CH, CHAr), 126.9 (CH, CHAr), 122.6 (CH, NCH=),
54.2 (CH2, PhCH2CH2N), 51.4 (CH2, CH2NMe2), 44.9 (CH2, PhCH2), 36.6 (CH3).
4-Phenyl-1-(3-phenyl-2-propenyl)-1H-1,2,3-triazole (10g). Using the general procedure 250 mg (96%)
of the title compound were prepared from azide 9e (159 mg) and phenylacetylene (112 μL).
Spectroscopic data for 10g were consistent with previously reported data for this compound [21].
1H-NMR (CDCl3): δ 7.84–7.82 (m, 3H, HAr + NCH=C), 7.43–7.39 (m, 4H, HAr), 7.36–7.32 (m, 4H,
HAr), 6.72 (d, J = 16.0 Hz, 1H, PhCH=CH), 6.40 (dt, J = 16.0, 6.5 Hz, 1H, PhCH=CH), 5.20 (d, J = 6.5 Hz,
13
2H, CH2N). C-NMR (CDCl3): δ 148.0 (C, NCH=C), 135.4 (C, CAr), 135.2 (CH, CHAr), 130.5 (C,
CAr), 128.7 (CH, CHAr), 128.6 (CH, CHAr), 128.4 (CH, CHAr), 128.0 (CH, CHAr), 126.6 (CH, PhCH=),
125.6 (CH, PhCH=CH), 121.8 (CH, CHAr), 119.3 (CH, NCH=), 52.3 (CH2, CH2N).
Dimethyl(1-phenyl-1H-1,2,3-triazol-4-ylmethyl)amine (10h). Using the general procedure 196 mg
(97%) of the title compound were prepared from phenyl azide (9f, 107 μL) and dimethylprop-2-
ynylamine (111 μL). Spectroscopic data for 10h were consistent with previously reported data for this
1
compound [22]. H-NMR (CDCl3): δ 7.95 (s, 1H, NCH=C), 7.74 (d, J = 8.0 Hz, 2H, HAr), 7.53 (t,
J = 8.0, 2H, HAr), 7.43 (t, J = 8.0 Hz, 1H, HAr), 3.71 (s, 2H, CH2NMe2), 2.34 (s, 6H, NMe2). 13C-NMR
(CDCl3): δ 146.0 (C, NCH=C), 137.0 (C, CAr), 129.6 (CH, CHAr), 128.5 (CH, CHAr), 120.4 (CH,
NCH=), 120.3 (CH, CHAr), 54.3 (CH2, CH2N), 45.2 (CH3).